# Treatment of Methicillin-sensitive Staphylococcus Aureus (MSSA)

> **NCT01500837** · NA · COMPLETED · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 23 (actual)

## Conditions studied

- Osteoarticular Infection

## Interventions

- **DRUG:** association of RIFAMPIN + CLINDAMYCIN
- **DRUG:** association of LEVOFLOXACIN+ CLINDAMYCIN

## Key facts

- **NCT ID:** NCT01500837
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-10
- **Primary completion:** 2011-10
- **Final completion:** 2011-10
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2013-09-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01500837

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01500837, "Treatment of Methicillin-sensitive Staphylococcus Aureus (MSSA)". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT01500837. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*